| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | Australia | 3 | |
| #4 | Canada | 3 | |
| #5 | Israel | 3 | |
| #6 | WIPO (World Intellectual Property Organization) | 3 | |
| #7 | China | 2 | |
| #8 | Russian Federation | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Special acyclic compounds | |
| #4 | Sugars | |
| #5 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Karpeisky Alexander | 22 |
| #2 | Zinnen Shawn | 19 |
| #3 | Guzaev Andrei P | 7 |
| #4 | Urlam Murali | 7 |
| #5 | Vvedensky Vladimir Y | 7 |
| #6 | Mikhailov Sergey | 3 |
| #7 | Zinnen Shawn Patrick | 3 |
| #8 | Padioukova Nelly | 3 |
| #9 | Tzeitline Grigorii | 3 |
| #10 | Dixon H B F | 3 |
| Publication | Filing date | Title |
|---|---|---|
| AU2018206453A1 | Drug combination treatments using bone-targeting therapeutics for bone and bone-related disease | |
| CA3064392A1 | Ibandronate conjugates of nucleoside antimetabolites | |
| US2014051625A1 | Bone targeted therapeutics and methods of making and using the same | |
| EP2739154A1 | Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates | |
| US7598246B2 | Bisphosphonate conjugates and methods of making and using the same | |
| EP2260852A2 | Bisphosphonate conjugates and methods of making and using the same |